Cyclosporine Worked Faster than Mycophenolate Mofetil or Azathioprine for Lupus Nephritis
June 12, 2019
A study presented at EULAR showed that ongoing maintenance therapy with the immunosuppressive drug cyclosporine helped lower...
Search Results
You searched for: lupus nephritis
Results found: 1120
FDA Accepts Application for Gazyva® as Potential Lupus Nephritis Treatment
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is eager to share exciting news. The U.S....
Lupus Research Alliance Pleased to Share Positive News about Potential Drug for Lupus Nephritis
NEW YORK, NY. June 11, 2019. The Lupus Research Alliance is pleased to share positive topline results from a...
Aurinia Completes NDA and Requests Priority Review of Voclosoporin by FDA for Lupus Nephritis
May 28, 2020
The Lupus Research Alliance is pleased to share that Aurinia Pharmaceuticals Inc submitted a New Drug Application...
Study Finds Mycophenolate Mofetil Comparable to Standard Treatment for Pediatric Lupus Nephritis
March 19, 2019
A new study published in Lupus showed that mycophenolate mofetil (MMF) is comparable in effectiveness to the...
LRA-Funded Researcher Finds New Biomarkers for Lupus Nephritis
August 7, 2019
Dr. Chandra Mohan discovered that blood clotting proteins are higher in the urine of people with lupus...
Lupus Research Alliance Awards $3 Million to Advance Pediatric Lupus Nephritis Diagnosis and Treatment
The Lupus Research Alliance (LRA) is pleased to announce that the 2023 Global Team Science Award (GTSA) has been...
LRA Pleased to Share News of Lupus Nephritis Clinical Trial Launch
October 1, 2019
The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...
LRA-funded Research Backs New Lupus Nephritis Clinical Trial
February 28, 2019
The biotechnology company Equillium Inc. just announced plans for a Phase 1 study to test the investigational...
LRA-Funded Study Sheds Light on Childhood Lupus Nephritis
A study partly funded by the Lupus Research Alliance (LRA) and published in Science Translational Medicine used advanced technology...
SGLT2 inhibition as a novel treatment for lupus nephritis
Ferroptosis as a novel driver of inflammation in lupus nephritis